Device Trial Radar · NCT01373580
A Clinical Trial to Evaluate a Corneal Inlay for the Improvement of Near Vision in Presbyopic Patients
Last checked: Nov 19, 2026Latest source record: Mar 29, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
373
Actual
Start
Apr 2010
Primary completion
Dec 2016
Study completion Dec 2016
Sponsor
- Lead sponsor
- ReVision Optics, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Jun 15, 2011
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 35 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study will be a prospective, multicenter clinical trial in which a total of 400 subjects will be enrolled. All subjects will be followed over a 36 month time frame with a maximum of 15 clinical sites participating. Qualified subjects will provide informed consent for entry into the study.
Conditions
- Presbyopia
Interventions
The Raindrop Near Vision InlayDevice
The Raindrop Near Vision Inlay is implanted in the cornea for treatment of presbyopia
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Improvement in Uncorrected Near Visual Acuity (20/40 or Better) in the Implanted EyeTime frame: 24 Months
Locations
11 sites in 1 country. Site status is shown where the registry gives one.
Dougherty Laser Vision
Camarillo, California
Harvard Eye Associates
Laguna Hills, California
Coastal Vision
Newport Beach, California
8 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.